Format

Send to:

Choose Destination
See comment in PubMed Commons below
Ann Pharmacother. 2001 Jun;35(6):755-64.

L-arginine in the management of cardiovascular diseases.

Author information

  • 1Arnold & Marie Schwartz College of Pharmacy and Health Sciences, 75 DeKalb Ave., Brooklyn, NY 11201-5497, USA. jcheng@liu.edu

Erratum in

  • Ann Pharmacother 2001 Jul-Aug;35(7-8):965. Balwin SN [corrected to Baldwin SN].

Abstract

OBJECTIVE:

To examine the role of L-arginine in the management of cardiovascular diseases.

DATA SOURCES:

A MEDLINE search (1966-April 2000) of review articles, using the search terms arginine, nitric oxide, and cardiovascular diseases, was conducted. After reviewing these articles, primary studies using the search terms arginine, hypercholesterolemia, hypertension, diabetes, smoking, ischemic heart disease, and heart failure were reviewed.

STUDY SELECTION:

English-language human studies were selected and evaluated based on quality of review.

DATA SYNTHESIS:

Small-scale studies have demonstrated that intravenous L-arginine augments endothelial function by enhancing vasodilation and reducing monocyte adhesion. Oral supplementation demonstrated similar effects as well as improvement of exercise ability in patients with cardiovascular diseases.

CONCLUSIONS:

L-arginine improves the management of multiple cardiovascular diseases. However, most published human studies are small. Before therapy can be routinely recommended, larger, well-designed studies are required to confirm its effect.

PMID:
11408995
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Write to the Help Desk